Weekly paclitaxel and carboplatin followed by topotecan (TC-TP), as first-line therapy for patients with advanced epithelial ovarian cancer (AOC) suboptimally debulked. Updated preliminary results

Weekly Paclitaxel ◽

First Line ◽

Preliminary Results ◽

First Line Therapy ◽

Line Therapy ◽

COMPARISON OF IFOSFAMIDE VERSUS CYCLOPHOSPHAMIDE IN COMBINATION WITH CISPLATIN AND DOXORUBICIN (ADRIAMYCIN), AS FIRST-LINE THERAPY FOR ADVANCED EPITHELIAL OVARIAN-CANCER - REPORT OF A PILOT-STUDY

Oncology Reports ◽

10.3892/or.1.3.631 ◽

1994 ◽

Author(s):

RE HEMPLING ◽

MS PIVER ◽

TR BAKER ◽

AM STANTON ◽

DL DRISCOLL

Keyword(s):

Ovarian Cancer ◽

Pilot Study ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.017 ◽

2006 ◽

Vol 103 (2) ◽

pp. 439-445 ◽

Cited By ~ 8

Author(s):

C.B. Steer ◽

K. Chrystal ◽

K.A. Cheong ◽

E. Galani ◽

G.M. Marx ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.5034 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5034-5034 ◽

Cited By ~ 1

Author(s):

K. Chrystal ◽

C. B. Steer ◽

K. A. Cheong ◽

E. Galani ◽

A. Strickland ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5034 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5034-5034

Author(s):

K. Chrystal ◽

C. B. Steer ◽

K. A. Cheong ◽

E. Galani ◽

A. Strickland ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Use of OvaRex(r) MAb-b43.13 as an immunotherapeutic treatment of epithelial ovarian cancer: experience as single agent post first-line therapy and in combination with chemotherapy in recurrent disease

European Journal of Cancer ◽

10.1016/s0959-8049(02)81106-6 ◽

2002 ◽

Vol 38 ◽

pp. S137

Keyword(s):

Ovarian Cancer ◽

Recurrent Disease ◽

Single Agent ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Cancer Experience

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

Gynecologic Oncology ◽

10.1006/gyno.2000.5778 ◽

2000 ◽

Vol 77 (2) ◽

pp. 271-277 ◽

Cited By ~ 4

Author(s):

Nadine Tung ◽

Ross Berkowitz ◽

Ursula Matulonis ◽

Marc Quartulli ◽

Michael Seiden ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Phase I Trial ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Advanced Epithelial Ovarian Cancer ◽

Stimulating Factor

Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapy

Gynecologic Oncology ◽

10.1016/0090-8258(89)90593-3 ◽

1989 ◽

Vol 33 (1) ◽

pp. 1-5 ◽

Cited By ~ 63

Author(s):

Mitchell Morris ◽

David M. Gershenson ◽

J.Taylor Wharton

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

First Line ◽

First Line Therapy ◽

Secondary Cytoreductive Surgery ◽

Line Therapy

Continuous infusion of ifosfamide and cisplatin as first-line therapy of patients with suboptimally debulked stage III-IV epithelial ovarian cancer

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.1998.97110.x ◽

1998 ◽

Vol 8 (2) ◽

pp. 138-143 ◽

Cited By ~ 2

Author(s):

Malik ◽

Khan ◽

Hussain ◽

Moid ◽

...

Keyword(s):

Ovarian Cancer ◽

Continuous Infusion ◽

Stage Iii ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Preliminary results from phase II trial of pembrolizumab with first line platinum based chemotherapy followed by maintenance pembrolizumab for patients with suboptimally cytoreduced advanced epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.05.202 ◽

2020 ◽

Vol 159 ◽

pp. 146-147

Author(s):

D. Uyar ◽

C.M. Michener ◽

W.H. Bradley ◽

E. Bishop ◽

P.G. Rose ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Preliminary Results ◽

Platinum Based Chemotherapy ◽

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

The Pharmacogenomics Journal ◽

10.1038/tpj.2016.63 ◽

2016 ◽

Vol 17 (6) ◽

pp. 506-514 ◽

Cited By ~ 5

Author(s):

S Pontikakis ◽

C Papadaki ◽

M Tzardi ◽

M Trypaki ◽

M Sfakianaki ◽

...

Keyword(s):

Ovarian Cancer ◽

Predictive Value ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Brca1 Brca2